Intellicheck Mobilisa Inc (IDN)vsZepp Health Corp (ZEPP)
IDN
Intellicheck Mobilisa Inc
$7.99
+0.13%
TECHNOLOGY · Cap: $160.50M
ZEPP
Zepp Health Corp
$17.47
+4.55%
TECHNOLOGY · Cap: $247.54M
Smart Verdict
WallStSmart Research — data-driven comparison
Zepp Health Corp generates 1042% more annual revenue ($258.90M vs $22.67M). IDN leads profitability with a 5.6% profit margin vs -15.5%. IDN earns a higher WallStSmart Score of 55/100 (C-).
IDN
Buy55
out of 100
Grade: C-
ZEPP
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+8.3%
Fair Value
$5.19
Current Price
$7.99
$2.80 discount
Margin of Safety
+48.6%
Fair Value
$46.70
Current Price
$17.47
$29.23 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 230.6% YoY
Strong operational efficiency at 22.5%
Reasonable price relative to book value
Revenue surging 43.0% year-over-year
Areas to Watch
Smaller company, higher risk/reward
ROE of 6.6% — below average capital efficiency
5.6% margin — thin
Premium valuation, high expectations priced in
Smaller company, higher risk/reward
ROE of -17.2% — below average capital efficiency
Earnings declined 68.1%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : IDN
The strongest argument for IDN centers on EPS Growth, Operating Margin. Revenue growth of 11.8% demonstrates continued momentum. PEG of 1.31 suggests the stock is reasonably priced for its growth.
Bull Case : ZEPP
The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.
Bear Case : IDN
The primary concerns for IDN are Market Cap, Return on Equity, Profit Margin. A P/E of 113.3x leaves little room for execution misses.
Bear Case : ZEPP
The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.
Key Dynamics to Monitor
IDN profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.
ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.
ZEPP is growing revenue faster at 43.0% — sustainability is the question.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
IDN scores higher overall (55/100 vs 41/100) and 11.8% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Intellicheck Mobilisa Inc
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Intellicheck, Inc., a technology company, develops, integrates and markets threat identification and identity authentication solutions for retail and banking fraud prevention, law enforcement threat identification, and mobile security and access control systems and laptops, primarily in the United States. The company is headquartered in Melville, New York.
Zepp Health Corp
TECHNOLOGY · CONSUMER ELECTRONICS · China
Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.
Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?